Devarajan Karunagaran

7.2k total citations · 2 hit papers
99 papers, 5.9k citations indexed

About

Devarajan Karunagaran is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Devarajan Karunagaran has authored 99 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 39 papers in Cancer Research and 22 papers in Oncology. Recurrent topics in Devarajan Karunagaran's work include MicroRNA in disease regulation (23 papers), Cancer-related molecular mechanisms research (17 papers) and Circular RNAs in diseases (13 papers). Devarajan Karunagaran is often cited by papers focused on MicroRNA in disease regulation (23 papers), Cancer-related molecular mechanisms research (17 papers) and Circular RNAs in diseases (13 papers). Devarajan Karunagaran collaborates with scholars based in India, United States and Israel. Devarajan Karunagaran's co-authors include Eldad Tzahar, Yosef Yarden, Barry Ratzkin, Ruby John Anto, Sara Lavi, Gil Levkowitz, Ramachandran Rashmi, Hadassa Waterman, Siddavaram Nagini and S. Asha Nair and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Devarajan Karunagaran

96 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Hierarchical Network of Interreceptor Interactions Determines Signal Transduction by Neu Differentiation Factor/Neuregulin and Epidermal Growth Factor

1996 831 citations Eldad Tzahar, Gil Levkowitz et al. Molecular and Cellular Biology profile →
ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.

1996 547 citations Devarajan Karunagaran, Eldad Tzahar et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Devarajan Karunagaran India	39	3.4k	2.2k	1.2k	970	501	99	5.9k
Xiaolin Zi United States	39	2.9k 0.9×	1.3k 0.6×	405 0.4×	663 0.7×	262 0.5×	102	4.8k
Asfar S. Azmi United States	51	6.7k 2.0×	3.4k 1.5×	166 0.1×	3.0k 3.1×	816 1.6×	217	10.5k
Sanjeev Banerjee United States	57	6.8k 2.0×	3.4k 1.6×	151 0.1×	2.8k 2.9×	432 0.9×	106	11.0k
Xingming Deng United States	52	5.5k 1.6×	1.8k 0.9×	114 0.1×	1.0k 1.1×	172 0.3×	103	7.4k
Gabriella D’Orazi Italy	43	3.8k 1.1×	2.3k 1.1×	109 0.1×	1.5k 1.5×	189 0.4×	131	6.3k
Ramzi M. Mohammad United States	41	2.9k 0.9×	1.2k 0.6×	131 0.1×	601 0.6×	273 0.5×	154	4.8k
Dejuan Kong United States	50	6.2k 1.8×	3.1k 1.4×	122 0.1×	3.6k 3.7×	233 0.5×	100	9.0k
Ulrich Pfeffer Italy	41	3.6k 1.1×	1.3k 0.6×	220 0.2×	1.2k 1.2×	99 0.2×	143	6.3k
Shi‐Yong Sun United States	56	7.2k 2.1×	2.7k 1.2×	139 0.1×	1.5k 1.5×	205 0.4×	203	9.5k
Yiwei Li United States	55	7.0k 2.1×	3.9k 1.8×	135 0.1×	3.6k 3.7×	322 0.6×	135	11.3k

Countries citing papers authored by Devarajan Karunagaran

Since Specialization

Citations

This map shows the geographic impact of Devarajan Karunagaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devarajan Karunagaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devarajan Karunagaran more than expected).

Fields of papers citing papers by Devarajan Karunagaran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devarajan Karunagaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devarajan Karunagaran. The network helps show where Devarajan Karunagaran may publish in the future.

Co-authorship network of co-authors of Devarajan Karunagaran

This figure shows the co-authorship network connecting the top 25 collaborators of Devarajan Karunagaran. A scholar is included among the top collaborators of Devarajan Karunagaran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devarajan Karunagaran. Devarajan Karunagaran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Karunagaran, Devarajan, et al.. (2025). Mechanistic insights into hypoxia‐induced metabolic reprogramming in colorectal cancer through genome‐scale modeling. Biotechnology Progress. 41(3). e70002–e70002. 1 indexed citations

Sakthivel, Ramasamy, et al.. (2024). Combinatorial Effects of 5-Fluorouracil and Menadione on Wnt/β-Catenin Pathway in Human Colorectal Cancer Cells. Applied Biochemistry and Biotechnology. 197(2). 1280–1300. 1 indexed citations

Mohanty, Suchitra, et al.. (2022). RETRA induces necroptosis in cervical cancer cells through RIPK1, RIPK3, MLKL and increased ROS production. European Journal of Pharmacology. 920. 174840–174840. 27 indexed citations

Karunagaran, Devarajan, et al.. (2020). Reactive Pt(II) center as part of redox-active quinoline-based heterocyclic scaffolds toward new anticancer leads. Bioorganic & Medicinal Chemistry Letters. 30(22). 127594–127594. 5 indexed citations

Ghosh, Debasmita, Mohammad Bodiuzzaman, Anirban Som, et al.. (2019). Internalization of a Preformed Atomically Precise Silver Cluster in Proteins by Multistep Events and Emergence of Luminescent Counterparts Retaining Bioactivity. The Journal of Physical Chemistry C. 123(48). 29408–29417. 11 indexed citations

Karunagaran, Devarajan, et al.. (2016). microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells. Cellular Oncology. 40(2). 119–131. 41 indexed citations

Karunagaran, Devarajan, et al.. (2016). MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells. British Journal of Cancer. 115(6). 741–751. 48 indexed citations

Nair, Cherupally Krishnan Krishnan, et al.. (2014). Evaluation of Cytotoxic and Anti-Tumor Activities of Coscinium fenestratum Extract. American journal of phytomedicine and clinical therapeutics. 2(12). 1346–1360. 2 indexed citations

Karunagaran, Devarajan, et al.. (2014). HPV16 E2-mediated potentiation of NF-κB activation induced by TNF-α involves parallel activation of STAT3 with a reduction in E2-induced apoptosis. Molecular and Cellular Biochemistry. 394(1-2). 77–90. 10 indexed citations

10.

Karthikeyan, Chandrabose, N. S. Hari Narayana Moorthy, Ramasamy Sakthivel, et al.. (2014). Advances in Chalcones with Anticancer Activities. Recent Patents on Anti-Cancer Drug Discovery. 10(1). 97–115. 229 indexed citations

11.

Karunagaran, Devarajan, et al.. (2013). MicroRNA-106b-25 cluster targets β-TRCP2, increases the expression of Snail and enhances cell migration and invasion in H1299 (non small cell lung cancer) cells. Biochemical and Biophysical Research Communications. 434(4). 841–847. 60 indexed citations

12.

Karunagaran, Devarajan, et al.. (2007). Anti-inflammatory effect of curcumin involves downregulation of MMP-9 in blood mononuclear cells. International Immunopharmacology. 7(13). 1659–1667. 70 indexed citations

13.

Karunagaran, Devarajan, Jeena Joseph, & T. R. Santhosh Kumar. (2007). CELL GROWTH REGULATION. Advances in experimental medicine and biology. 595. 245–268. 24 indexed citations

14.

Bava, Smitha V., et al.. (2004). Sensitization of Taxol-induced Apoptosis by Curcumin Involves Down-regulation of Nuclear Factor-κB and the Serine/Threonine Kinase Akt and Is Independent of Tubulin Polymerization. Journal of Biological Chemistry. 280(8). 6301–6308. 190 indexed citations

15.

Maliekal, Tessy Thomas, Ruby John Anto, & Devarajan Karunagaran. (2004). Differential Activation of Smads in HeLa and SiHa Cells That Differ in Their Response to Transforming Growth Factor-β. Journal of Biological Chemistry. 279(35). 36287–36292. 23 indexed citations

16.

Srinivas, Gopal, et al.. (2003). Emodin induces apoptosis of human cervical cancer cells through poly(ADP-ribose) polymerase cleavage and activation of caspase-9. European Journal of Pharmacology. 473(2-3). 117–125. 168 indexed citations

17.

Karunagaran, Devarajan, Eldad Tzahar, Naili Liu, Duanzhi Wen, & Yosef Yarden. (1995). Neu Differentiation Factor Inhibits EGF Binding. Journal of Biological Chemistry. 270(17). 9982–9990. 51 indexed citations

18.

Lu, Hsieng S., David Chang, John S. Philo, et al.. (1995). Studies on the Structure and Function of Glycosylated and Nonglycosylated neu Differentiation Factors. Journal of Biological Chemistry. 270(9). 4784–4791. 38 indexed citations

19.

Tzahar, Eldad, Gil Levkowitz, Devarajan Karunagaran, et al.. (1994). ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms.. Journal of Biological Chemistry. 269(40). 25226–25233. 234 indexed citations

20.

Wen, Duanzhi, Sidney V. Suggs, Devarajan Karunagaran, et al.. (1994). Structural and Functional Aspects of the Multiplicity of Neu Differentiation Factors. Molecular and Cellular Biology. 14(3). 1909–1919. 202 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact